N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice

Neurochemistry International
Rena C BaekThomas N Seyfried

Abstract

Sandhoff disease involves the CNS accumulation of ganglioside GM2 and asialo-GM2 (GA2) due to inherited defects in the beta-subunit gene of beta-hexosaminidase A and B (Hexb gene). Accumulation of these glycosphingolipids (GSLs) produces progressive neurodegeneration, ultimately leading to death. Substrate reduction therapy (SRT) aims to decrease the rate of glycosphingolipid (GSL) biosynthesis to compensate for the impaired rate of catabolism. The imino sugar, N-butyldeoxygalactonojirimycin (NB-DGJ) inhibits the first committed step in GSL biosynthesis. NB-DGJ treatment, administered from postnatal day 2 (p-2) to p-5 (600 mg/kg/day)), significantly reduced total brain ganglioside and GM2 content in the Sandhoff disease (Hexb(-/-)) mice, but did not reduce the content of GA2. We also found that NB-DGJ treatment caused a slight, but significant elevation in brain sialidase activity. The drug had no adverse effects on viability, body weight, brain weight, or brain water content in the mice. No significant alterations in neutral lipids or acidic phospholipids were observed in the NB-DGJ-treated Hexb(-/-) mice. Our results show that NB-DGJ is effective in reducing total brain ganglioside and GM2 content at early neonatal ages.

References

Jan 1, 1991·Annual Review of Biochemistry·E F Neufeld
Sep 30, 1974·Molecular and Cellular Biochemistry·R CaputtoA Arce
Dec 1, 1971·Journal of Neurochemistry·K SandhoffH Jatzkewitz
Sep 1, 1984·Neuropediatrics·K Sandhoff, E Conzelmann
Jun 1, 1984·Experimental Neurology·T N SeyfriedR K Yu
Dec 1, 1980·Biochemical Genetics·T N Seyfried, R K Yu
Oct 23, 1997·Glycoconjugate Journal·J MatsudaM Naiki
May 8, 1998·Molecular Medicine Today·C Chavany, M Jendoubi
Feb 18, 1999·The Journal of Clinical Investigation·Y LiuR L Proia
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M JeyakumarF M Platt
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·R WadaR L Proia
Feb 13, 2001·Biochemical and Biophysical Research Communications·T HasegawaT Miyagi
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·C G GiraudoH J Maccioni
Jun 19, 2001·Journal of Inherited Metabolic Disease·F M PlattA Zimran
Apr 4, 2002·Drugs·Raphael Schiffmann, Roscoe O Brady
May 23, 2002·Human Molecular Genetics·Rachel MyerowitzRichard L Proia
Oct 9, 2002·Neuropathology and Applied Neurobiology·M JeyakumarF M Platt
Feb 7, 2003·Current Topics in Medicinal Chemistry·Terry D ButtersFrances M Platt
Jun 14, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Terry D ButtersFrances M Platt
Jun 14, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Frances M PlattTerry D Butters
Jun 14, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Chris Moyses
Aug 6, 2003·The Journal of Biological Chemistry·Claudio G Giraudo, Hugo J F Maccioni
Nov 8, 2003·Journal of Inherited Metabolic Disease·T M CoxUNKNOWN Advisory Council to the European Working Group on Gaucher Disease
Dec 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Junichiro MatsudaYoshiyuki Suzuki
Jan 16, 2004·The Journal of Biological Chemistry·Michael B TropakDon Mahuran
Apr 17, 2004·Journal of Neurochemistry·Julie L KasperzykThomas N Seyfried
May 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yun-Ping Wu, Richard L Proia
Jun 17, 2004·Journal of Neurochemistry·Rosaria BuccolieroAnthony H Futerman
Jun 23, 2004·Seminars in Cell & Developmental Biology·Luba GinzburgAnthony H Futerman

❮ Previous
Next ❯

Citations

Feb 27, 2010·Glycoconjugate Journal·Stephanie D BoomkampTerry D Butters
May 1, 1996·Obstetrics and Gynecology·L E CaulfieldR J Stoltzfus
Apr 20, 2014·Obesity Research & Clinical Practice·Ranil JayawardenaAndrew P Hills
May 22, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Allison M BradburyDouglas R Martin
Nov 1, 2011·Glycobiology·Adriana R RinflerchPablo F Argibay
Mar 23, 2011·Human Molecular Genetics·Jacqueline A Hawkins-SalsburyMark S Sands
Jul 12, 2007·Journal of Negative Results in Biomedicine·Melanie A McNallyDaniel A Kirschner
Mar 10, 2010·Journal of Lipid Research·You-Hai XuGregory A Grabowski
Nov 13, 2008·Neurochemical Research·Thomas N SeyfriedChristine A Denny
Jan 22, 2011·Neurochemical Research·Karie A HeineckeThomas N Seyfried
Mar 1, 2012·Neurochemical Research·J R ArthurT N Seyfried
Feb 19, 2013·Neurochemical Research·Julian R ArthurThomas N Seyfried
Mar 9, 2010·Brain Research Bulletin·Cara-Lynne Schengrund
Oct 7, 2008·Neurochemistry International·Ana Flávia FurianCarlos Fernando Mello
Jul 25, 2015·Lipids·Zeynep AkgocThomas N Seyfried
Jul 8, 2016·International Journal of Molecular Sciences·Maria Francisca CoutinhoSandra Alves
Mar 22, 2015·Journal of Lipid Research·Zeynep AkgocThomas N Seyfried
Nov 20, 2018·Journal of Neurochemistry·Helen Parker, Brian W Bigger
Mar 21, 2020·Journal of Nephrology·Sandro Feriozzi, Derralynn A Hughes
Jun 28, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hannah G LaheyMiguel Sena-Esteves

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.